LUBBOCK, Texas & AUSTIN, Texas--(BUSINESS WIRE)--The National Institute of Dental and Craniofacial Research (NIDCR), one of the National Institutes of Health (NIH), has issued a two-year $912,943 grant to biopharmaceutical company Selenium, Ltd. to support the development of antimicrobial dental devices and water lines. In the two-part grant the NIH has approved $492,972 for year one and $419,971 for year two dependent on achieving year one objectives. The company’s SeLECTTM technology addresses the need for a safer, more effective and less costly antimicrobial or antineoplastic coating technology that can reduce risk of contamination or infection in the dentist’s office.
